Inventors list |
Assignees list |
Classification tree browser |
Top 100 Inventors |
Top 100 Assignees |
Fradet
Eric Fradet, Le Tignet FR
| Patent application number | Description | Published |
|---|---|---|
| 20110127381 | HARNESS WITH ADJUSTABLE BACK STRAP - A maintaining equipment with variable length side transverse strap segments in with the one side fastening strap, includes two pairs of saddle straps connected via saddle straps, to either the back transverse strap, back straps crossing the container backrest, or extension of the side transverse straps. The latter extends into a side fastening strap. A loop at a location locatable from the waist to the leg straps is run through by the side fastening strap or the side transverse strap. Strap tightening can occur at hooking or thereafter, allowing adjustment of the side transverse strap and the side fastening strap to maintain the container on the solo skydiver's back or maintain the passenger to the tandem pilot during freefall. Unlocking and/or loosening after canopy deployment elongates the side transverse strap with shortening of the side fastening strap allowing backward movement of the lower back and progression of the leg straps. | 06-02-2011 |
Eric Fradet, Tallard FR
| Patent application number | Description | Published |
|---|---|---|
| 20080272238 | Equipment for a jump in an oversized parachute - The present invention relates to an equipment for jump in an oversized parachute for carrying a pilot ( | 11-06-2008 |
| 20080308680 | Device to improve the positioning of a retardation system of a parachute canopy by magnetism - The device enables the gradual opening of the parachute canopy, round or square, during the spreading phase of the canopy ( | 12-18-2008 |
| 20090127395 | Interlock reserve parachute deployment system - A device, system and method of reserve parachute deployment comprising; a reserve bridle | 05-21-2009 |
Erwan Fradet, Cottens CH
| Patent application number | Description | Published |
|---|---|---|
| 20110093113 | METHODS AND SYSTEMS FOR MAKING, TRACKING AND AUTHENTICATION OF PRODUCTS - Manufactured goods are marked or labeled with a secure unique identifier. A central checking centre allows users to verify the authenticity of a particular good such as a cigarette pack or carton via any convenient interface such as the internet or a cell phone. A system of secret sharing allows secure authentication of each item and prevents code breaking or misuse. | 04-21-2011 |
Erwan Fradet, Denens CH
| Patent application number | Description | Published |
|---|---|---|
| 20090230190 | METHOD AND APPARATUS FOR IDENTIFYING, AUTHENTICATING, TRACKING AND TRACING MANUFACTURED ITEMS - A method and apparatus for identifying manufactured items in containers, where each container is suitable for containing two or more units, and where the method comprises the steps of: associating each unit with a unique unit identifier, uniquely identifying each unit, allocating two or more units to be contained in each container, uniquely identifying each container, for each container, determining one or more ranges of unit identifiers of the two or more units allocated to the container, and storing, in a database, a container identifier for each container, each container identifier being coupled, in the database, to the one or more ranges of unit identifiers of the two or more units allocated to the container. There is also provided methods and apparatus for authenticating, tracking and tracing the units. | 09-17-2009 |
Erwan Fradet, Nyon CH
| Patent application number | Description | Published |
|---|---|---|
| 20110154046 | METHOD AND APPARATUS FOR STORAGE OF DATA FOR MANUFACTURED ITEMS - Exemplary embodiments are directed to a method and apparatus for storage of data for a batch of manufactured items. The method comprises defining, by a lower limit identifier and an upper limit identifier, a range of unique item identifiers for the batch, wherein each manufactured item in the batch is allocated a unique item identifier falling within the range. The number of unique item identifiers allocated to the manufactured items is smaller than the number of unique item identifiers in the range. The unique item identifiers allocated to the manufactured items are defined by the lower limit item identifier of the range, the upper limit item identifier of the range and an indication of those item identifiers in the range which are not allocated to a manufactured item. | 06-23-2011 |
Joseph Aurele Jacque Fradet, Valley Center, CA US
| Patent application number | Description | Published |
|---|---|---|
| 20120110861 | Eating Fork With Reverse Tapered Tines - An improved eating fork includes a conventional handle and an extended flat body portion with a plurality of tines that generally taper continuously from narrowest to widest towards the open ends of the fork. The tines taper outward up to the maximum relative width towards the open end of the fork, and the thickness of the tines in this invention reduces gradually towards the open ends. By the increased width and a reduced thickness of the tines towards the end, this invention provides more efficiency in spearing a food item, in scooping a food item, in capturing through a twisting motion of the tines, and in holding or retaining the food item once it has either been initially speared, scooped, or twisted, than a conventional fork. | 05-10-2012 |
Yves Fradet, Sillery CA
| Patent application number | Description | Published |
|---|---|---|
| 20080261228 | PCA3 Messenger RNA Species in Benign and Malignant Prostate Tissues - This invention concerns the discovery of two distinct PCA3 mRNA sequences. One of these sequences corresponds to a short PCA3 mRNA molecule whereas the other PCA3 RNA molecule is longer as it comprises an additional sequence between exon 3 and exon 4a. The short RNA is associated with prostate cancer whereas the long RNA sequence is associated with a non-malignant state of the prostate. Based on the differential expression levels of these two PCA3 RNA sequences, protocols for the diagnosis of prostate disease are provided. The invention also relates to therapeutic approaches to prostate cancer. | 10-23-2008 |
| 20110165573 | METHOD TO DETECT PROSTATE CANCER IN A SAMPLE - The present invention relates to prostate cancer. More specifically, the present invention relates to a method to detect prostate cancer in a patient sample by detecting the RNA encoded by the gene PCA3. More particularly the present invention relates to a method for determining a predisposition, or presence of prostate cancer in a patient comprising: (a) contacting a biological sample of a patient with at least one oligonucleotide that hybridizes to a PCA3 polynucleotide; (b) detecting in the biological sample an amount of PCA3 and second prostate specific polynucleotides; and (c) comparing the amount of PCA3 polynucleotide that hybridizes to the oligonucleotide to a predetermined cut off value, and therefrom determining the presence or absence of prostate cancer in the biological sample. The present invention further relates to diagnostic kits for the detection of prostate cancer or the risk of developing same in a patient comprising: (a) at least one container means having disposed therein at least one oligonucleotide probe or primer that hybridizes to one a PCA3 nucleic acid or complement thereof; (b) at least one oligonucleotide probe or primer that hybridizes with a second prostate specific nucleic acid or complement thereof; and (c) reagents enabling a detection of PCA3 and of the second prostate specific nucleic acid when PCA3 or second prostate-specific nucleic acid sequence is present. | 07-07-2011 |
Yves Fradet, Quebec CA
| Patent application number | Description | Published |
|---|---|---|
| 20090028888 | Cancer Antigen Mage-A9 and Uses Thereof - The present invention relates to the detection of MAGE-A9 in a biological sample and to the diagnosis, prevention and treatment of MAGE-A9-associated aberrant cell growth, through the targeting of the MAGE-A9 polypeptide and/or polynucleotide. Diagnosis is accomplished by examining or monitoring cells for perturbations in MAGE-A9 expression. Prevention and treatment are accomplished by administering to a subject MAGE-A9 as a protein or a fragment thereof or under form of a DNA expression vector, as well as by administering to a subject a MAGE-A9 gene product-binding agent. Compositions and commercial kits are also provided. | 01-29-2009 |
| 20100129824 | DISTINGUISHING PCA3 MESSENGER RNA SPECIES IN BENIGN AND MALIGNANT PROSTATE TISSUES - This invention concerns the discovery of two distinct PCA3 mRNA sequences. One of these sequences corresponds to a short PCA3 mRNA molecule whereas the other PCA3 RNA molecule is longer as it comprises an additional sequence between exon 3 and exon 4a. The short RNA is associated with prostate cancer whereas the long RNA sequence is associated with a non-malignant state of the prostate. Based on the differential expression levels of these two PCA3 RNA sequences, protocols for the diagnosis of prostate disease are provided. The invention also relates to therapeutic approaches to prostate cancer. | 05-27-2010 |
| 20110212449 | DISTINGUISHING PCA3 MESSENGER RNA SPECIES IN BENIGN AND MALIGNANT PROSTATE TISSUES - This invention concerns the discovery of two distinct PCA3 mRNA sequences. One of these sequences corresponds to a short PCA3 mRNA molecule whereas the other PCA3 RNA molecule is longer as it comprises an additional sequence between exon 3 and exon 4a. The short RNA is associated with prostate cancer whereas the long RNA sequence is associated with a non-malignant state of the prostate. Based on the differential expression levels of these two PCA3 RNA sequences, protocols for the diagnosis of prostate disease are provided. The invention also relates to therapeutic approaches to prostate cancer. | 09-01-2011 |